Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03080337 · ClinicalTrials.gov registry record · NA

Group vs. Traditional Diabetes Prenatal Care

A NA study, sponsored by University of Wisconsin, Madison.

Terminated
Registry status
NA
Development phase
12
Enrollment target

NCT03080337: Clinical Trial NA study, sponsored by University of Wisconsin, Madison.

NCT03080337 is a NA study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03080337, a NA study, was terminated before completion, sponsored by University of Wisconsin, Madison.

TERMINATED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This study aims to use an innovative and integrated educational curriculum to deliver prenatal care and diabetes care for pre-gestational diabetic women from approximately the first trimester of pregnancy through delivery and the early postpartum period in a group care model. The group care model will be compared to a control group, a traditional, individual care model.

Primary Outcome

Compare the glucose compliance of participants in the group care model to the control group: a traditional, individual care model.

Interventions

  • OTHER Group Care

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2017-03-17
Est. Completion 2018-02-22
Phase NA
University of Wisconsin, Madison

1,039 total trials

Why NCT03080337 stopped before completion

NCT03080337 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Group Care is the first listed.

NCT03080337 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03080337 about?

NCT03080337 is a clinical study titled "Group vs. Traditional Diabetes Prenatal Care". This study aims to use an innovative and integrated educational curriculum to deliver prenatal care and diabetes care for pre-gestational diabetic women from approximately the first trimester of pregnancy through delivery and the early postpartum period in a group care model. The group care model wi...

What is the current status of trial NCT03080337?

This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2017-03-17. Estimated completion is 2018-02-22.

What interventions are being tested in trial NCT03080337?

The interventions under investigation include: Group Care (OTHER).

Who is sponsoring clinical trial NCT03080337?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03080337's enrollment target sits among peer trials

12 1913th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03080337, the US trial registry maintained by the National Library of Medicine. NCT03080337 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.